SGLT2is: The New Pillar in Heart Failure Care



What You Will Learn

  • Identify clinical indications and key considerations for selection of SGLT2 inhibitors

  • Establish a contemporary prescribing timeline for SGLT2 inhibitors

  • Practical considerations of SGLT2is including initiation, dosing, and monitoring

  • Overcome barriers to SGLT2i initiation
Meeting On Demand

An educational activity that has been recorded for viewing

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:


Alison L. Bailey, MD, FACC


James L. Januzzi, Jr., MD, FACC


Nosheen Reza, MD, FACC


Shashank S. Sinha, MD, FACC


Muthiah Vaduganathan, MD, FACC



Supported by an independent educational grant from: AstraZeneca and Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company | Page Launched: April 2022

Android App Download IOS App Download Powered By